Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan

Drug Safety

Volumn 40, Issue 12, 2017, Pages 1219-1229

  Ozawa, Kazuki ^a   Hineno, Akiyo ^a,b   Kinoshita, Tomomi ^a   Ishihara, Sakiko ^b   Ikeda, Shu ichi ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; ALLODYNIA; ARTHRALGIA; ARTICLE; BACKACHE; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CHRONIC CONSTIPATION; DIAGNOSTIC VALUE; DIARRHEA; DYSAUTONOMIA; FAINTNESS; FATIGUE; FEMALE; FEVER; FOREARM INJURY; HEADACHE; HUMAN; HYPERVENTILATION; JAPAN; LEARNING DISORDER; LIMB DYSESTHESIA; LIMB TREMOR; LOW BACK PAIN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; MOTOR DYSFUNCTION; NEURALGIA; PAIN; PATIENT IDENTIFICATION; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRIORITY JOURNAL; RELIABILITY; RESTLESS LEGS SYNDROME; SENSORY DYSFUNCTION; SHOULDER PAIN; SLEEP DISORDER; TACHYCARDIA; TEMPORAL ANALYSIS; VACCINATION; VACCINATION REACTION; VALIDITY; ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; PAPILLOMAVIRUS INFECTION; PREVALENCE; SPATIOTEMPORAL ANALYSIS; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; JAPAN; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; SPATIO-TEMPORAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 85025802361     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-017-0574-6     Document Type: Article

References (40)

1. FUTURE II study group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915–27.
2. Jeurissen S, Makar A. Epidemiological and economic impact of human papillomavirus vaccines. Int J Gynecol Cancer. 2009;19:761–71.
3. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/topics/bcg/tp250330-2.html. 2017. Accessed 16 Jul 2017. (in Japanese).
4. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/stf/shingi/2r98520000034g8f-att/2r98520000034hr8_2.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
5. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/stf/shingi/2r98520000034g8f-att/2r98520000034hrr_2.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
6. All Japan Coordinating Association of HPV Vaccine Sufferers. http://hpvv-danger.jp (in Japanese). 2017. Accessed 16 Jul 2017. (in Japanese).
7. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/pdf/kankoku_h25_6_01.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
8. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000161349.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
9. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000161329.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
10. Kinoshita T, Abe R, Hineno A, Tsunekawa K, Nakane S, Ikeda S. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. Intern Med. 2014;53:2185–200.
11. Matsudaira T, Takahashi Y, Matsuda K, Ikeda H, Usui K, Obi T, et al. Cognitive dysfunction and regional cerebral blood flow changes in Japanese females after human papillomavirus vaccination. Neurol Clin Neurosci. 2016;4:220–7.
12. Anaya JM, Reyes B, Perdomo-Arciniegas AM, Camacho-Rodríguez B, Rojas-Villarraga A. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombian: a call for personalized medicine. Clin Exp Rheumatol. 2015;33:545–8.
13. Pellegrino P, Perrone V, Pozzi M, Carnovale C, Perrotta C, Clementi E, et al. The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the vaccine adverse event reporting systems. Immunol Res. 2015;61:90–6.
14. Tanaka H, Fujita Y, Takenaka Y, Kajiwara S, Masutani S, Ishizaki Y, et al. Japanese clinical guidelines for juvenile orthostatic dysregulation version 1. Pediatr Int. 2009;51:169–79.
15. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen WK, Schondorf R, et al. Postural tachycardia syndrome (POTS). Neurology. 1995;45:S19–25.
16. Okubo S. Digital plethysmogram. In: Kanai M, editor. Manual of clinical and laboratory medicine. 31st ed. Tokyo: Kanehara Publishing Inc.; 1998. p. 1546–7 (in Japanese).
17. Okazaki T, Saeki S, Hachisuka K. Adolescent normative data on simple neuropsychological tests for cognitive behavioral disorders: mini-mental State examination, trail making test, Wisconsin card sorting Test-KFS version and Miyake’s verbal paired-associate learning test. Jpn J Rehabil Med. 2013;50:962–70 (in Japanese).
18. Nishioka K, Yokota S, Matsumoto Y. Clinical features and preliminary diagnostic criteria for human papillomavirus vaccination associated with neuroimmunopathic syndrome (HANS). Int J Rheum Dis. 2014;17:6.
19. Ushida T, Shibata M, Kitahara M, Yabuki S, Sumitani M, Murakami T, et al. The effect of guidance regarding home exercise and ADL on adolescent females suffering from adverse effects after HPV vaccination in Japanese multidisciplinary pain centers. Pain Res Manag. 2016;2016:3689352.
20. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA. 2009;302:750–7.
21. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al. Extensive validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. Pain. 1999;81:147–54.
22. Martínez-Lavín M. Hypothesis: human papillomavirus vaccination syndrome-small fiber neuropathy and dysautonomia could be its underlying pathogenesis. Clin Rheumatol. 2015;34:1165–9.
23. Carnovale C, Damavandi PT, Gentili M, Pozzi M, Antoniazzi S, Radice S, et al. On the association between human papillomavirus vaccine and sleep disorders: evaluation based on vaccine adverse events reporting systems. J Neurol Sci. 2017;373:179–81.
24. Hirai T, Kuroiwa Y, Hayashi T, Uchiyama M, Nakamura I, Yokota S, et al. Adverse effects of human papilloma virus vaccination on central nervous system: neuro-endocrinological disorders of hypothalamo-pituitary axis. Auton Nerv Syst. 2016;53:49–64.
25. Takahashi Y, Matsudaira T, Nakano H, Nasu H, Ikeda H, Nakaoka K, et al. Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination. J Neuroimmunol. 2016;298:71–8.
26. Brinth L, Theibel AC, Pors K, Mehlsen J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J. 2015;62:A5064.
27. Brinth LS, Pors K, Theibel AC, Mehlsen J. Orthostatic intolerance and postural tachycardia syndrome as suspected adverse effects of vaccination against human papilloma virus. Vaccine. 2015;33:2602–5.
28. Palmieri B, Poddighe D, Vadalà M, Laurino C, Carnovale C, Clementi E. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature. Immuno Res. 2017;65(1):106–16.
29. Martínez-Lavín M. Fibromyalgia-like illness in 2 girls after human papillomavirus vaccination. J Clin Rheumatol. 2014;20:392–3.
30. Martínez-Lavín M, Martínez-Martínez LA, Reyes-Loyola P. HPV vaccination syndrome: a questionnaire-based study. Clin Rheumatol. 2015;34:1981–3.
31. ®. Drug Saf. 2017;40:81–90.
32. Shoenfeld Y, Agmon-Levin N. ASIA-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4–8.
33. Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1–16.
34. Hendrickson JE, Tormey CA. Human papilloma virus vaccination and dysautonomia: considerations for autoantibody testing and HLA typing. Vaccine. 2016;34:4468.
35. Blitshteyn S, Brook J. Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination. Immunol Res. 2017;65(1):282–4.
36. Gisselquist DP. Estimating HIV-1 transmission efficiency through unsafe medical injections. Int J STD AIDS. 2002;13:152–9.
37. Mahboobi N, Agha-Hosseini F, Safari S, Lavanchy D, Alavian SM. Hepatitis B virus infection in dentistry: a forgotten topic. J Viral Hepat. 2010;17:307–16.
38. Wilder RT. Management of pediatric patients with complex regional pain syndrome. Clin J Pain. 2006;22:443–8.
39. The Ministry of Health, Labour and Welfare. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000161329.pdf. 2017. Accessed 16 Jul 2017. (in Japanese).
40. Aratani S, Fujita H, Kuroiwa Y, Usui C, Yokota S, Nakamura I, et al. Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin. Sci Rep. 2016;6:36943.